614 related articles for article (PubMed ID: 29187392)
1. Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.
Wang A; Liu X; Xu J; Han X; Su Z; Chen S; Zhang N; Wu S; Wang Y; Wang Y
J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187392
[TBL] [Abstract][Full Text] [Related]
2. Impact of Visit-to-Visit Fasting Plasma Glucose Variability on the Development of Type 2 Diabetes: A Nationwide Population-Based Cohort Study.
Kim JA; Lee JS; Chung HS; Roh E; Lee YB; Hong SH; Kim NH; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi KM
Diabetes Care; 2018 Dec; 41(12):2610-2616. PubMed ID: 30254081
[TBL] [Abstract][Full Text] [Related]
3. The association between fasting plasma glucose and all-cause and cause-specific mortality by gender: The rural Chinese cohort study.
Liu L; Chen X; Liu Y; Sun X; Yin Z; Li H; Zhang M; Wang B; Ren Y; Zhao Y; Liu D; Zhou J; Liu X; Zhang D; Cheng C; Liu F; Zhou Q; Xu Q; Xiong Y; Liu J; You Z; Hong S; Wang C; Hu D
Diabetes Metab Res Rev; 2019 May; 35(4):e3129. PubMed ID: 30657630
[TBL] [Abstract][Full Text] [Related]
4. Visit-to-visit fasting blood glucose variability and lifetime risk of cardiovascular disease: a prospective study.
Bi J; Song L; Wang L; Wu M; Chen S; Wang Y; Wu S; Tian Y
Cardiovasc Diabetol; 2021 Oct; 20(1):207. PubMed ID: 34656122
[TBL] [Abstract][Full Text] [Related]
5. Reversion From Pre-Diabetes Mellitus to Normoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in a Chinese Population: A Prospective Cohort Study.
Liu X; Wu S; Song Q; Wang X
J Am Heart Assoc; 2021 Feb; 10(3):e019045. PubMed ID: 33496188
[TBL] [Abstract][Full Text] [Related]
6. Long-term glucose variability and incident cardiovascular diseases and all-cause mortality events in subjects with and without diabetes: Tehran Lipid and Glucose Study.
Barzegar N; Ramezankhani A; Tohidi M; Azizi F; Hadaegh F
Diabetes Res Clin Pract; 2021 Aug; 178():108942. PubMed ID: 34245796
[TBL] [Abstract][Full Text] [Related]
7. Normal fasting plasma glucose predicts type 2 diabetes and cardiovascular disease in elderly population in Taiwan.
Huang CL; Chang HW; Chang JB; Chen JH; Lin JD; Wu CZ; Pei D; Hung YJ; Lee CH; Chen YL; Hsieh CH
QJM; 2016 Aug; 109(8):515-22. PubMed ID: 26576838
[TBL] [Abstract][Full Text] [Related]
8. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study.
Wei M; Gaskill SP; Haffner SM; Stern MP
Diabetes Care; 1998 Jul; 21(7):1167-72. PubMed ID: 9653614
[TBL] [Abstract][Full Text] [Related]
9. Fasting plasma glucose variability and all-cause mortality among type 2 diabetes patients: a dynamic cohort study in Shanghai, China.
Xu D; Fang H; Xu W; Yan Y; Liu Y; Yao B
Sci Rep; 2016 Dec; 6():39633. PubMed ID: 28004765
[TBL] [Abstract][Full Text] [Related]
10. Fasting Plasma Glucose Variability and Gastric Cancer Risk in Individuals Without Diabetes Mellitus: A Nationwide Population-Based Cohort Study.
Hong SH; Noh E; Kim J; Hwang SY; Kim JA; Lee YB; Roh E; Choi KM; Baik SH; Cho GJ; Yoo HJ
Clin Transl Gastroenterol; 2020 Sep; 11(9):e00221. PubMed ID: 32858572
[TBL] [Abstract][Full Text] [Related]
11. Annual fasting plasma glucose variation increases risk of cancer incidence and mortality in patients with type 2 diabetes: the Taichung Diabetes Study.
Lin CC; Li CI; Liu CS; Lin WY; Chen CC; Yang SY; Lee CC; Li TC
Endocr Relat Cancer; 2012 Aug; 19(4):473-83. PubMed ID: 22544890
[TBL] [Abstract][Full Text] [Related]
12. Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI.
Yang CD; Shen Y; Ding FH; Yang ZK; Hu J; Shen WF; Zhang RY; Lu L; Wang XQ
Cardiovasc Diabetol; 2020 Sep; 19(1):131. PubMed ID: 32878604
[TBL] [Abstract][Full Text] [Related]
13. Fasting plasma glucose variability levels and risk of adverse outcomes among patients with type 2 diabetes: A systematic review and meta-analysis.
Zhao Q; Zhou F; Zhang Y; Zhou X; Ying C
Diabetes Res Clin Pract; 2019 Feb; 148():23-31. PubMed ID: 30583033
[TBL] [Abstract][Full Text] [Related]
14. Variation of fasting plasma glucose: a predictor of mortality in patients with type 2 diabetes.
Lin CC; Li CI; Yang SY; Liu CS; Chen CC; Fuh MM; Chen W; Li TC
Am J Med; 2012 Apr; 125(4):416.e9-18. PubMed ID: 22305579
[TBL] [Abstract][Full Text] [Related]
15. Association of Visit-to-Visit Variability in Fasting Plasma Glucose with Digestive Cancer Risk.
Zhang N; Wang Y; Tse G; Li G; Wu S; Liu T
Oxid Med Cell Longev; 2022; 2022():4530894. PubMed ID: 35873802
[TBL] [Abstract][Full Text] [Related]
16. Relations of Postload and Fasting Glucose With Incident Cardiovascular Disease and Mortality Late in Life: The Cardiovascular Health Study.
Brutsaert EF; Shitole S; Biggs ML; Mukamal KJ; deBoer IH; Thacker EL; Barzilay JI; Djoussé L; Ix JH; Smith NL; Kaplan RC; Siscovick DS; Psaty BM; Kizer JR
J Gerontol A Biol Sci Med Sci; 2016 Mar; 71(3):370-7. PubMed ID: 26314953
[TBL] [Abstract][Full Text] [Related]
17. Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study.
Echouffo-Tcheugui JB; Zhao S; Brock G; Matsouaka RA; Kline D; Joseph JJ
Diabetes Care; 2019 Mar; 42(3):486-493. PubMed ID: 30659073
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Trajectories of Fasting Plasma Glucose and Risks of Cardiovascular Diseases in Middle Age to Elderly People Within the General Japanese Population: The Suita Study.
Ogata S; Watanabe M; Kokubo Y; Higashiyama A; Nakao YM; Takegami M; Nishimura K; Nakai M; Kiyoshige E; Hosoda K; Okamura T; Miyamoto Y
J Am Heart Assoc; 2019 Feb; 8(3):e010628. PubMed ID: 30686107
[TBL] [Abstract][Full Text] [Related]
19. Optimal cutoff values of fasting plasma glucose (FPG) variability for detecting retinopathy and the threshold of FPG levels for predicting the risk of retinopathy in type 2 diabetes: A longitudinal study over 27 years.
Takao T; Inoue K; Suka M; Yanagisawa H; Iwamoto Y
Diabetes Res Clin Pract; 2018 Jun; 140():228-235. PubMed ID: 29625141
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term glycemic variability on incident cardiovascular disease and mortality in subjects without diabetes: A nationwide population-based study.
Yu JH; Han K; Park S; Lee DY; Nam GE; Seo JA; Kim SG; Baik SH; Park YG; Kim SM; Kim NH; Choi KM
Medicine (Baltimore); 2019 Jul; 98(29):e16317. PubMed ID: 31335679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
